Medtap International, Inc.

Medtap International, Inc. develops innovative healthcare solutions that enhance patient outcomes through advanced telehealth platforms and health management tools, focused on improving healthcare accessibility and efficiency. Founded in 1984 and headquartered in Bethesda, US, Medtap International, Inc. specializes in telehealth and health management solutions.

In January 2004, the company was acquired by United BioSource Corporation, a portfolio company of Grotech, JH Whitney, and Oak Investment Partners. Medtap. com specializes in innovative healthcare solutions designed to enhance patient outcomes and streamline medical processes. The company's primary product offerings include advanced telehealth platforms that facilitate remote consultations between healthcare providers and patients, as well as comprehensive health management tools that empower users to monitor their health metrics effectively.

These services aim to address critical challenges in healthcare delivery, such as accessibility, efficiency, and patient engagement. Medtap. com targets a diverse client base, including hospitals, clinics, and individual practitioners, primarily operating in North America and select European markets. The end users of these services encompass patients seeking convenient healthcare access and medical professionals aiming to optimize their practice management.

Medtap. com generates revenue primarily through a subscription-based model, allowing healthcare providers to access its telehealth and health management platforms. Clients typically engage in contract agreements that stipulate monthly or annual fees for platform usage, which can vary based on the scale of service and number of users. Additionally, partnerships with healthcare institutions create avenues for revenue through collaborative service offerings and integrated solutions.

Specific pricing details are structured according to the features and capabilities of the platforms utilized, ensuring that healthcare providers can select plans that fit their operational needs and patient engagement strategies. The firm’s flagship products, which leverage proprietary technology, are central to its revenue generation, solidifying its presence in the evolving digital health landscape. The most recent deal involving Medtap International occurred in January 2004 when it was acquired by United BioSource Corporation. Looking ahead, Medtap has plans to innovate its product offerings, with new telehealth solutions in development expected to enhance patient engagement and operational efficiency.

The company is also strategizing to expand into European markets by 2025, aiming to introduce its services in key regions like Germany and the UK.